Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis
2017
ObjectiveThe current study demonstrated the potential use of calcineurin inhibitor (CNI) in combination therapy for interstitial lung disease (ILD) complicated with dermatomyositis (DM) and polymyositis (PM).MethodsThirty DM/PM patients with ILD were enrolled in this study. Continuous intravenous ad
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
34
References
19
Citations
NaN
KQI